ZENAS BIOPHARMA, INC. — Income Charts
10 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↓-100.0% -$5M
$0
R&D↑+13.4% +$7M
$56M
D&A↓-69.7% -$23K
$10K
Operating Income↓-28.3% -$12M
$-53M
EBITDA↓-69.7% -$23K
$10K
Other Income/Expense↓-54.5% -$1M
$1M
Pretax Income↓-33.4% -$13M
$-51M
Tax Provision
$106K
Net Income↓-33.4% -$13M
$-51M
Operating Margin
-373.3%
Net Margin
-335.7%
Effective Tax Rate
-0.0%
ETR (Continuing Operations)↑+0.3pts
0.0%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↓-6.4pts
0.0%
ETR Foreign Differential (pp)↑+7.8pts
0.2%
Operating Lease Cost↓-33.3% -$100K
$200K
Revenue YoY Variation
-100.0%
Income YoY Variation↑+186.8pts
-28.3%
Revenue QoQ Variation
-100.0%
Income QoQ Variation↑+7.9pts
4.7%